Nuvectis Pharma (NVCT) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order with directors and independent auditors introduced in attendance remotely.

• Legal counsel and inspector of elections roles identified; agenda included voting on business matters described in the proxy statement.

Overview of voting outcomes

• Quorum confirmed with majority of shares represented as of April 13, 2026.

• Voting conducted on two items: election of a director and ratification of the independent auditor.

• Election of director for a term until the 2029 annual meeting approved.

• Ratification of Kesselman & Kesselman as independent auditor for 2026 fiscal year approved.

• Complete voting results to be filed in Form 8-K with the SEC and posted on the company website.